Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Characteristics of interview participants (n= 42)

From: Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study

Characteristic  
Age in years, Mean (SD), Range 13.4 (2.1), 10-17
Sex, n (%)  
  Male 32 (76.2)
  Female 10 (23.8)
Ethnicity, n (%)  
  White British 36 (85.7)
  Mixed/Multiple ethnic groups 6 (14.3)
Co-occurring conditions as reported by child’s parent (may be more than one condition), n (%) 20 (47.6)
  Attention-deficit/hyperactivity disorder 9 (21.4)
  Obsessive compulsive disorder 7 (16.7)
  Autism spectrum disorder 6 (14.3)
  Anxiety 4 (9.5)
  Other 5 (11.9)
Treatment for tics, n (%)  
  Medication 23 (54.8)
  Behavioural intervention 8 (19.0)
  No medication or behavioural intervention 18 (42.9)
Medication for tics, n (%)  
  Clonidine 12 (28.6)
  Risperidone 11 (26.2)
  Aripiprazole 10 (23.8)
  Haloperidol 3 (7.1)
  Diazepam 2 (4.8)
  Lorazepam 2 (4.8)
  Sertraline 2 (4.8)
  Atomoxetine 1 (2.4)
  Clonazepam 1 (2.4)
  Methylphenidate 1 (2.4)
  Penicillin 1 (2.4)
  Procyclidine 1 (2.4)